parkinson glutathione oxidative ipsc crispr Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR-Cas systems CRISPR And iPSC Disease Modeling

These data suggest that the anticoagulant used for sample collection and time to deproteinization, both independently and additively impact measured levels of free GSH (and thus the ratio of free GSH to GSSG) in samples of plasma which are deproteinized and stored at 80 o C

Here's the honest version, because you deserve it: 5-Amino-1MQ is not an overnight fix, and anyone promising a specific number on the scale by a specific date is guessing

0.3 volumes of Balance-DTT buffer were added to the supernatant immediately

Translational research must prioritize the development of validated biomarkers of MP exposure and toxicity, such as fecal or urinary MP levels, gut barrier integrity, and systemic inflammation markers

As we age, collagen production decreases, leading to wrinkles and loss of skin elasticity

A diversity of diatom-derived and dinoflagellate-derived sulfur metabolites are shown to support heterotrophic bacterial growth